4.4 Review

Arthritis in Systemic Sclerosis: Systematic Review of the Literature and Suggestions for the Performance of Future Clinical Trials in Systemic Sclerosis Arthritis

期刊

SEMINARS IN ARTHRITIS AND RHEUMATISM
卷 41, 期 6, 页码 801-814

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.semarthrit.2011.10.003

关键词

systemic sclerosis; scleroderma; arthritis in systemic sclerosis; musculoskeletal involvement in systemic sclerosis; quality of life; function

资金

  1. NIH
  2. EULAR
  3. Abbot
  4. Actelion
  5. Amgen
  6. BMS
  7. Novartis
  8. Pfizer
  9. Roche
  10. Genetech
  11. UCB
  12. GSK

向作者/读者索取更多资源

Objectives: Musculoskeletal (MSK) pain is a frequent (between 40-80%) complaint of patients with systemic sclerosis (SSc). Unfortunately, there are virtually no systematic studies of the causes or the management of MSK involvement in SSc and with few exceptions there have been no controlled trials to determine what are and should be the best strategies for managing MSK pain and synovitis in patients with SSc. Methods: A literature search was conducted for published reports that have addressed the clinical assessment of arthritis and musculoskeletal involvement in SSc. The literature search was a prelude to developing recommendations/suggestions for performing clinical trials (preferably randomized) in the future in SSc-related arthritis. Results: The search netted a number of articles that reported clinical assessments of arthritis in SSc, but very few reported results of controlled clinical trials. Nevertheless, a prevalence of clinical arthritis and tools used to assess the involvement (clinical examination, functional assessments and assessments of quality of life, and radiographic imaging) was found. Conclusions: Most of the tools used to assess arthritis in SSc patients have not been validated and additional work is needed to develop a core set of variables for assessment of arthritis in SSc and its response to treatment. This report furnishes the background information that can help provide the building blocks for the development of a core set that can be used to chart the efficacy of new treatments for SSc-related arthritis in the future. (C) 2012 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 41:801-814

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据